Limited evidence shows that medicines derived from plants (so-called phytomedicines) may help reduce painful crises in sickle cell disease, according to a Cochrane review of 2 trials involving 282 participants. Among the findings:
- Niprisan may help to reduce episodes of sickle cell disease crises associated with severe pain, though further trials are required to fully assess its role.
- Ciklavit requires further study before recommendations can be made regarding its use.
- No serious adverse symptoms or derangement of liver or kidney function was reported with either formulation.
Oniyangi O, Cohall D. Phytomedicines (medicines derived from plants) for sickle cell disease. Cochrane Database of Systematic Reviews 2018, Issue 2. Art. No.: CD004448. doi:10.1002/14651858.CD004448.pub6.
This Week's Must Reads
Bortezomib looks promising in WM mutations, Sklavenitis-Pistofidis R et al. Blood. 2018 Oct 26. doi: 10.1182/blood-2018-07-863241
Patient perspectives on NHL treatment, Chircop D et al. Eur J Oncol Nurs. 2018 Aug;35:117-21
Patient blood management in stem cell transplant, Jambhekar N et al. AABB 2018, Abstract PBM3-ST4-22
BTK inhibitor shows phase 1 results in Waldenstrom’s macroglobulinemia, Leukemia & Lymphoma 2018
Immune system changes play a role in AML relapse, Christopher MJ et al. N Engl J Med. 2018 Oct 31. doi: 10.1056/NEJMoa1808777.
Must Reads in Bleeding Disorders
Avatrombopag reduces procedure-related transfusions in chronic liver disease and thrombocytopenia, Terrault N et al. Gastroenterology. 2018 May 17. doi: 10.1053/j.gastro.2018.05.025.
Prehospital plasma improves odds of survival in hemorrhagic shock, Sperry JL et al. N Engl J Med. 2018 Jul 26;379(4):315-26.
Thrombocytopenia in pregnancy raises risk of complications, Reese J et al. N Engl J Med. 2018;379:32-43.
Red cell tranfusion may increase risk of postsurgical VTE, Goel R et al. JAMA Surg. 2018 Jun 13. doi: 10.1001/jamasurg.2018.1565
Dapagliflozin suppresses hepcidin, boosts hematocrit, Ghanim HA et al. AACE 2018, Abstract 228.